These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11462298)

  • 1. Pharmacokinetics of echocontrast agent infusion in a dog model.
    Kaps M; Seidel G; Algermissen C; Gerriets T; Broillet A
    J Neuroimaging; 2001 Jul; 11(3):298-302. PubMed ID: 11462298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial duplex imaging with a sulfurhexafluoride echocontrast agent: enhancement and diagnostic quality.
    Schweikert K; Operschall C; Llull JB; Lyrer P
    J Neuroimaging; 2002 Jan; 12(1):19-27. PubMed ID: 11826593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion versus bolus of an ultrasound contrast agent: in vivo dose-response measurements of BR1.
    Correas JM; Burns PN; Lai X; Qi X
    Invest Radiol; 2000 Jan; 35(1):72-9. PubMed ID: 10639038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SonoVue in transcranial Doppler investigations of the cerebral arteries.
    Kaps M; Legemate DA; Ries F; Ackerstaff RG; Markus H; Pezzoll C; Llull JB; Spinazzi A
    J Neuroimaging; 2001 Jul; 11(3):261-7. PubMed ID: 11462292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and ultrasound-enhancing potentials of a new sulfur hexafluoride-containing agent in the cerebral circulation.
    Kaps M; Seidel G; Bokor D; Modrau B; Algermissen C
    J Neuroimaging; 1999 Jul; 9(3):150-4. PubMed ID: 10436756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent Microembolic Signals in the Cerebral Circulation on Transcranial Doppler after Intravenous Sulfur Hexafluoride Microbubble Infusion.
    Aarli SJ; Novotny V; Thomassen L; Kvistad CE; Logallo N; Fromm A
    J Neuroimaging; 2020 Mar; 30(2):146-149. PubMed ID: 31749218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of Doppler system settings on the clearance kinetics of different ultrasound contrast agents.
    Seidel G; Vidal-Langwasser M; Algermissen C; Gerriets T; Kaps M
    Eur J Ultrasound; 1999 May; 9(2):167-75. PubMed ID: 10413753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic studies of different echo-contrast agents in the cerebral circulation of dogs.
    Seidel G; Beller KD; Kaps M
    Ultrasound Med Biol; 1996; 22(8):1037-42. PubMed ID: 9004427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic vein transit time of SonoVue: a comparative study with Levovist.
    Lim AK; Patel N; Eckersley RJ; Goldin RD; Thomas HC; Cosgrove DO; Taylor-Robinson SD; Blomley MJ
    Radiology; 2006 Jul; 240(1):130-5. PubMed ID: 16720867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SonoVue, a new ultrasound contrast agent.
    Schneider M
    Eur Radiol; 1999; 9 Suppl 3():S347-8. PubMed ID: 10602926
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous grayscale and subharmonic ultrasound imaging on a modified commercial scanner.
    Eisenbrey JR; Dave JK; Halldorsdottir VG; Merton DA; Machado P; Liu JB; Miller C; Gonzalez JM; Park S; Dianis S; Chalek CL; Thomenius KE; Brown DB; Navarro V; Forsberg F
    Ultrasonics; 2011 Dec; 51(8):890-7. PubMed ID: 21621239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience.
    Albrecht T; Urbank A; Mahler M; Bauer A; Doré CJ; Blomley MJ; Cosgrove DO; Schlief R
    Radiology; 1998 May; 207(2):339-47. PubMed ID: 9577478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro contrast-enhanced ultrasound measurements of capillary microcirculation: comparison between polymer- and phospholipid-shelled microbubbles.
    Grishenkov D; Kari L; Brodin LK; Brismar TB; Paradossi G
    Ultrasonics; 2011 Jan; 51(1):40-8. PubMed ID: 20542310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-intensity-based quantification of vascularity with single-level dynamic contrast-enhanced ultrasonography: a pilot animal study.
    Li J; Dong BW; Yu XL; Wang XH; Li CF
    J Ultrasound Med; 2005 Jul; 24(7):975-83. PubMed ID: 15972712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface Charge Measurement of SonoVue, Definity and Optison: A Comparison of Laser Doppler Electrophoresis and Micro-Electrophoresis.
    Ja'afar F; Leow CH; Garbin V; Sennoga CA; Tang MX; Seddon JM
    Ultrasound Med Biol; 2015 Nov; 41(11):2990-3000. PubMed ID: 26318559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of echocontrast-enhanced transcranial arterial color-coded duplex ultrasound.
    Droste DW; Boehm T; Ritter MA; Dittrich R; Ringelstein EB
    Cerebrovasc Dis; 2005; 20(5):332-6. PubMed ID: 16131802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a novel ultrasound contrast agent with long persistence on right ventricular pressure: Comparison with SonoVue.
    Liu P; Wang X; Zhou S; Hua X; Liu Z; Gao Y
    Ultrasonics; 2011 Feb; 51(2):210-4. PubMed ID: 20825961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging.
    Morel DR; Schwieger I; Hohn L; Terrettaz J; Llull JB; Cornioley YA; Schneider M
    Invest Radiol; 2000 Jan; 35(1):80-5. PubMed ID: 10639039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cerebral autoregulation with transcranial Doppler sonography in poor bone windows using constant infusion of an ultrasound contrast agent.
    Lorenz MW; Thoelen N; Loesel N; Lienerth C; Gonzalez M; Humpich M; Roelz W; Dvorak F; Sitzer M
    Ultrasound Med Biol; 2008 Mar; 34(3):345-53. PubMed ID: 17976899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of microvascular blood flow by contrast-enhanced ultrasound (CEUS).
    Greis C
    Clin Hemorheol Microcirc; 2011; 49(1-4):137-49. PubMed ID: 22214685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.